Chandler and Grant's Glaucoma, w in its Fifth Edition, represents a timely update to one of the field's seminal texts on the medical practice and surgical management of glaucoma. Edited by Drs. Malik Y. Kahook and Joel S. Schuman and with contributions from David L. Epstein and over 50 contributors, Chandler and Grant's Glaucoma, Fifth Edition brings together the experience of world-class glaucoma experts who belong to a long line of surgeons trained by using the teachings of the original authors of this classic work. Meticulous updating from the previous edition maintains the well- established historical teachings of Drs. Paul A. Chandler and Morton W. Grant and defines this new Fifth Edition as the most relevant and invaluable reference on the topic of glaucoma. Exploring subject areas from the mechanisms behind clinical observation to the details on treating the individual patient in the office, Chandler and Grant's Glaucoma, Fifth Edition brings together the experience of world-class glaucoma experts trained from the original teachings of this book. New topics and features in the Fifth Edition: * Advances in imaging of the optic nerve and retina * Updates on medical therapy of glaucoma * New approaches for minimally invasive glaucoma surgery * Over 400 images and tables Chandler and Grant's Glaucoma has been an invaluable reference for the medical and surgical management of glaucoma for generations of ophthalmologists. This updated Fifth Edition builds on the teachings of previous editions, while expanding on new kwledge, making the Fifth Edition as relevant in the 21st century as when the first lectures were presented by Drs. Chandler and Grant.
Malik Y. Kahook, MD is Professor of Ophthalmology and Director of Clinical and Translational Research in the Department of Ophthalmology at the University of Colorado. He also directs the glaucoma service and glaucoma fellowship. Dr. Kahook specializes in the medical and surgical treatment of glaucoma and cataracts. He is active within the ophthalmology community, including memberships in the American Academy of Ophthalmology, American Glaucoma Society, American Society of Refractive and Cataract Surgeons, and the Association for Research in Vision and Ophthalmology. Dr. Kahook has authored more than 200 peer-reviewed manuscripts, abstracts, and book chapters, and is editor of 4 textbooks, including Essentials of Glaucoma Surgery (SLACK Incorporated). He is on the editorial board of the American Journal of Ophthalmology and International Glaucoma Review, among others. He was awarded an American Glaucoma Society Clinician-Scientist Fellowship Award for 2007, as well as the American Glaucoma Society Compliance Grant for 2006, and was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010. Dr. Kahook received the American Academy of Ophthalmology Achievement Award in 2011. He has filed for more than 12 patents, several of which have been licensed by companies for development and commercialization. He currently serves as a consultant to the US Food and Drug Administration's Ophthalmic Device Division. Dr. Kahook completed his residency training at the University of Colorado, Rocky Mountain Lions Eye Institute in Denver, Colorado, where he was named Chief Resident. He then went on to complete his fellowship in glaucoma from the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Joel S. Schuman, MD, FACS is the Eye and Ear Foundation Professor and Chairman of Ophthalmology, the Eye and Ear Institute, University of Pittsburgh School of Medicine and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He is also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh, and a Founder of the Louis J. Fox Center for Vision Restoration of UPMC and the University of Pittsburgh. He is a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh. Dr. Schuman is a native of Roslyn, New York; he graduated from Columbia University (BA, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following his internship at New York's Beth Israel Medical Center (1985), he completed residency training at Medical College of Virginia (1988) and glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989; research 1990), where he was a Heed Fellow. After just over a year on the Harvard faculty, he moved to the New England Medical Center, Tufts University, to co-found the New England Eye Center in 1991, where he was Residency Director and Glaucoma and Cataract Service Chief. In 1998, he became Professor of Ophthalmology, and Vice Chair in 2001. Dr. Schuman and his colleagues were the first to identify a molecular marker for human glaucoma, as published in Nature Medicine in 2001. He has been continuously funded by the National Eye Institute as a principal investigator since 1995, is principal investigator of a National Institutes of Health (NIH) grant to study novel glaucoma diagnostics, and is co-investigator of NIH grants for research into novel optical diagnostics and short pulse laser surgery and for advanced imaging in glaucoma. He is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 250 peer-reviewed scientific journal articles, has authored or edited 8 books, and has contributed more than 50 book chapters. In 2002, Dr. Schuman received the Alcon Research Institute Award, as well as the New York Academy of Medicine's Lewis Rudin Glaucoma Pr
Joel S. Schuman, Malik Y. Kahook, Paul Lee, Redleaf Press